Minimed Group, Inc.

MiniMed announces Health Canada License for Simplera Sync™ Sensor, Type 2 Diabetes Indication with MiniMed™ 780G System

MiniMed to announce financial results for its fourth quarter and full fiscal year 2026

MiniMed Announces FDA Clearance of MiniMed Flex™, the Company's Smallest Insulin Pump Featuring Its First Smartphone-Controlled Design

MiniMed announces closing of Initial Public Offering

MiniMed begins trading on Nasdaq Global Select Market